Literature DB >> 1519982

Serum erythropoietin concentrations in symptomatic infants during the anaemia of prematurity.

J Meyer1, A Sive, P Jacobs.   

Abstract

A comparison was carried out between a series of neonates who weighed less than 1500 g at birth and received red cell transfusions for symptomatic anaemia of prematurity (group 1, n = 14) and controls of similar gestational age and weight, who remained well and were not transfused during their nursery stay (group 2, n = 10). Mean (SD) haemoglobin concentrations at birth were 163 (12) g/l and 183 (17) g/l (p = 0.004), respectively. Transfusion resulted in significantly better weight gain in six infants who had been growing poorly:mean (SE) 8.8 (2.8) g/day improved to 23.3 (2.1) g/day (p less than 0.002). Geometric mean (SD) serum immunoreactive erythropoietin (SiEp) concentrations (17.7 (1.3) U/l) for the whole group of infants were similar to those of normal adults (17.4 (4.7) U/l) despite considerably reduced haemoglobin values. There was a significant inverse correlation between haemoglobin and log SiEp concentrations in the infants requiring transfusion (r = -0.43; p less than 0.01), but this was not apparent in the untransfused babies. Moreover, at haemoglobin concentrations below 120 g/l the mean (SE) SiEp concentration of 20 (1.08) U/l in group 1 was significantly higher than in group 2 (14 (1.06) U/l; p = 0.002). These data suggest that an increased concentration of SiEp early in the course of the anaemia of prematurity helps to identify those infants who would benefit from red cell transfusions, but that clinical criteria, although ill defined, do so equally well.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1519982      PMCID: PMC1590415          DOI: 10.1136/adc.67.7_spec_no.818

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  15 in total

1.  EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN.

Authors:  O H LOWRY; J V PASSONNEAU; F X HASSELBERGER; D W SCHULZ
Journal:  J Biol Chem       Date:  1964-01       Impact factor: 5.157

2.  Are regular 'top-up' transfusions necessary in otherwise well, growing premature infants?

Authors:  O J Ransome; E A Moosa; F M Mothebe; I Spector
Journal:  S Afr Med J       Date:  1989-02-18

3.  The anemia of prematurity. Factors governing the erythropoietin response.

Authors:  J A Stockman; J F Garcia; F A Oski
Journal:  N Engl J Med       Date:  1977-03-24       Impact factor: 91.245

4.  Weight gain: a response to transfusion in selected preterm infants.

Authors:  J A Stockman; D A Clark
Journal:  Am J Dis Child       Date:  1984-09

Review 5.  Anemia of prematurity.

Authors:  P R Dallman
Journal:  Annu Rev Med       Date:  1981       Impact factor: 13.739

6.  Nonphysiological anaemia of prematurity.

Authors:  C A Wardrop; B M Holland; K E Veale; J G Jones; O P Gray
Journal:  Arch Dis Child       Date:  1978-11       Impact factor: 3.791

7.  Anemia of prematurity: determinants of the erythropoietin response.

Authors:  J A Stockman; J E Graeber; D A Clark; K McClellan; J F Garcia; R E Kavey
Journal:  J Pediatr       Date:  1984-11       Impact factor: 4.406

8.  Postnatal changes in erythropoietin levels in untransfused premature infants.

Authors:  M S Brown; R H Phibbs; J F Garcia; P R Dallman
Journal:  J Pediatr       Date:  1983-10       Impact factor: 4.406

9.  Assessing the need for transfusion of premature infants and role of hematocrit, clinical signs, and erythropoietin level.

Authors:  W G Keyes; P K Donohue; J L Spivak; M D Jones; F A Oski
Journal:  Pediatrics       Date:  1989-09       Impact factor: 7.124

10.  Immunoradiometric assay of serum ferritin as a practical method for evaluating iron stores in infants and children.

Authors:  W S Dempster; D L Steyn; G J Knight; H Heese
Journal:  Med Lab Sci       Date:  1977-10
View more
  1 in total

1.  Plasma free iron: a possible cause of oedema in kwashiorkor.

Authors:  A A Sive; W S Dempster; H Malan; S Rosseau; H D Heese
Journal:  Arch Dis Child       Date:  1997-01       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.